Correlation Between Unicycive Therapeutics and OKYO Pharma
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and OKYO Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and OKYO Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and OKYO Pharma Ltd, you can compare the effects of market volatilities on Unicycive Therapeutics and OKYO Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of OKYO Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and OKYO Pharma.
Diversification Opportunities for Unicycive Therapeutics and OKYO Pharma
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Unicycive and OKYO is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and OKYO Pharma Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OKYO Pharma and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with OKYO Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OKYO Pharma has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and OKYO Pharma go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and OKYO Pharma
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 1.29 times more return on investment than OKYO Pharma. However, Unicycive Therapeutics is 1.29 times more volatile than OKYO Pharma Ltd. It trades about 0.04 of its potential returns per unit of risk. OKYO Pharma Ltd is currently generating about 0.01 per unit of risk. If you would invest 71.00 in Unicycive Therapeutics on September 6, 2024 and sell it today you would earn a total of 0.00 from holding Unicycive Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 99.8% |
Values | Daily Returns |
Unicycive Therapeutics vs. OKYO Pharma Ltd
Performance |
Timeline |
Unicycive Therapeutics |
OKYO Pharma |
Unicycive Therapeutics and OKYO Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Unicycive Therapeutics and OKYO Pharma
The main advantage of trading using opposite Unicycive Therapeutics and OKYO Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, OKYO Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OKYO Pharma will offset losses from the drop in OKYO Pharma's long position.Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
OKYO Pharma vs. Candel Therapeutics | OKYO Pharma vs. Anebulo Pharmaceuticals | OKYO Pharma vs. Cingulate Warrants | OKYO Pharma vs. Unicycive Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |